Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)

Conclusion This phase II study met the predefined primary endpoints, but its risk/benefit ratio was not satisfactory. (Source: International Journal of Clinical Oncology)

from MedWorm: Mesothelioma http://www.medworm.com/index.php?rid=151352894&cid=c_409_6_f&fid=33383&url=http%3A%2F%2Flink.springer.com%2F10.1007%2Fs10147-015-0925-1